ArticleFrontiers in cellular and infection microbiology2024
A novel pathogenic species of genus
Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Highly effective isolation ofMicrobiology spectrum · 2026Article
- Lactobacillus-derived extracellular vesicles provide multi-target acne treatment by enriched proteins and skin microbiota protection.Journal of nanobiotechnology · 2026Article
- Phylogenetic divergence drives distinct antimicrobial susceptibility profiles and resistomes inFrontiers in microbiology · 2026Article
- An update on novel taxa and revised taxonomic status of bacteria isolated from human clinical specimens described in 2024.Journal of clinical microbiology · 2025Review
- Bioactive Pigment Production by Stenotrophomonas rhizophila PB01: Partial Characterization and its Biological Applications.Current microbiology · 2025Article
- Microbiome Analysis of Area in Proximity to White Spot Lesions Reveals More Harmful Plant Pathogens in Maize.Biomolecules · 2025Article
- Article
- Validation List no. 220. Valid publication of new names and new combinations effectively published outside the IJSEM.International journal of systematic and evolutionary microbiology · 2024Article
- Revised taxonomic classification of theFrontiers in microbiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: The pathogenicity, immunological and biochemical characteristics of 610A2 Results: 610A2 Conclusions: The pathogenicity of 610A2
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.